Orient Biotech announced that its revenue for the first quarter of 2025 was 192 million yuan, an increase of 4.94% year-on-year; the net loss was 115 million yuan, compared to a net loss of 67.3535 million yuan in the same period last year
Orient Biotech announced that its revenue for the first quarter of 2025 was 192 million yuan, an increase of 4.94% year-on-year; the net loss was 115 million yuan, compared to a net loss of 67.3535 million yuan in the same period last year